Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Set To Change Drug-Pricing System

This article was originally published in PharmAsia News

Executive Summary

India's government is set to begin a new pricing system for pharmaceuticals, with thousands of the drugs expected to become available at lower prices. The new policy would end the drug maker practice of changing the size of a drug package or its potency to qualify for being allowed to charge higher prices. Instead, prices would be regulated on a pro-rated system that fixes a price for all strengths of a drug if the price is fixed for one. A new system also is seen as a way to get around the long delays by the government in catching up to a drug maker's price change. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts